BioLine RX Ltd (NASDAQ:BLRX)

0.3599
Delayed Data
As of Jun 26
 -0.0101 / -2.73%
Today’s Change
0.31
Today|||52-Week Range
1.84
-17.70%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for BioLine RX Ltd have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 2.00. The median estimate represents a +733.56% increase from the last price of 0.36.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in BioLine RX Ltd. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.04
Sales
$125.0K
Reporting Date
Aug 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 13.33%
 
 
 
 
 
 
Growthannually 16.59%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.